Month: March 2022

OLNEY, Md., March 03, 2022 (GLOBE NEWSWIRE) — Sandy Spring Bank has been named a top five bank by Forbes on its 2022 America’s Best Banks list. This is the second consecutive year that the Bank made the list. “We are pleased to be named one of the top banks in the U.S. This recognition comes on the heels of a record year for our Company, and it is a testament to our success in the marketplace and the trust our clients have in us,” said Daniel J. Schrider, President and CEO. “Thanks to our more than 1,150 dedicated employees, we are a nearly $13 billion company with a proven record of delivering results for our clients and value for our shareholders. I am proud of our employees for all of their hard work.” In 2021, Sandy Spring Bancorp reported record annual earnings of $235.1 million, $10 billion in total loans, $10.6 billion in...

Company invests $14.5 million to expand education for patients and physicians about NeuroStar® Advanced Therapy MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the launch of their new campaign to increase awareness of the impact of depression on millions of people. The campaign is called “Tap into a New Possibility” and illustrates how overwhelmed patients with major depressive disorder (MDD) feel about managing their condition, especially if they have not benefited from multiple treatment attempts.    “Too many people are suffering, and traditional treatments don’t work for everyone. It’s critical that...

Vaisala CorporationStock exchange releaseMarch 3, 2022, at 4:30 p.m. (EET) Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plans A total of 125,950 of Vaisala Corporation’s treasury shares have been conveyed without consideration to the 42 key employees participating in the Share-based incentive plan 2019–2021 under the terms and conditions of the plan. Of these shares, 2,000 were conveyed to the President and CEO Kai Öistämö. In addition, a total of 1,218 of Vaisala Corporation’s treasury shares have been conveyed without consideration to an employee participating in the Share-based incentive plans 2020–2022 and 2021–2023 under the terms and conditions of the plans. The directed share issue was based on an authorization given by the Annual General Meeting held on March 30, 2021. Following...

Pioneering Node-on-a-Blade technology will enable Windstream to offer transformative networking services LITTLE ROCK, Ark., and SAN JOSE, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Windstream Wholesale, a leading provider of advanced network solutions, and Infinera (NASDAQ: INFN) announced today plans to collaborate on an initiative to transform Windstream’s optical network infrastructure. The modernized network will enable Windstream to offer innovative new connectivity services optimized to seamlessly support the hyperscale capacity growth of its customers. As part of Windstream’s Intelligent Converged Optical Network (ICON) initiative, this collaboration will leverage pioneering optical networking technologies to provide a new level of control, visibility, and automation to Windstream’s optical network. The next-generation optical...

CINCINNATI, March 03, 2022 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of grocery-anchored omni-channel neighborhood shopping centers, today announced that it will present at the Citi 2022 Global Property CEO Conference Tuesday, March 8, 2022 at 3:30 p.m. Eastern Time. Presentation at Citi 2022 Global Property CEO ConferenceDate: Tuesday, March 8, 2022Time: 3:30 p.m. Eastern TimeSpeakers: Jeff Edison, Chief Executive Officer; Devin Murphy, President; John Caulfield, Chief Financial OfficerWebcast: https://kvgo.com/global-property-ceo-conference/phillips-edison-and-company-llc-mar-2022Company information to be presented at this conference and a webcast replay will be posted to the Company’s website at https://investors.phillipsedison.com. About...

Clinical data show AgenT-797 can be dosed to 1 billion cells without lymphodepletion, with no evidence of cytokine release syndrome or neurotoxicity Clinical trials underway in solid tumor cancers, multiple myeloma, and viral ARDSNEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, announced that it has begun dosing patients with solid tumor cancers with AgenT-797 alone and in combination with approved anti-PD-1 checkpoint inhibitors in a Phase 1 open-label clinical trial. “This is the first study to evaluate the use of native, allogeneic iNKTs in combination with approved checkpoint...